Flu Vaccines and Associated Supplies

The National Geospatial-Intelligence Agency seeks 2,000 single-dose units of Flucelvax Trivalent influenza vaccine with ancillary medical supplies for the 2026-2027 influenza season, with proposals due August 10, 2026, at 5:00 PM Central Time. Amendment 0001, issued July 31, removed the total small business set-aside clause, converting this to unrestricted competition; the original August 3 deadline was extended to August 10.

Place of performance is Springfield, Virginia, with vaccine and supplies distributed to NGA Washington (1,200 doses) and NGA St. Louis (800 doses). Delivery must be completed by September 30, 2026, during specified business hours at each facility. The contract is firm-fixed-price, awarded on a Lowest Price Technically Acceptable (LPTA) basis to the responsible offeror whose quote conforms to solicitation requirements.

Required supplies include FDA-approved, CDC-recommended Flucelvax Trivalent in pre-filled single-dose syringes, sterile gauze pads, band-aids, alcohol prep pads, safety-glide hypodermic needles (23G x 1"), disposable dental bibs, 3-layer disposable masks (750 total), powder-free nitrile gloves (large), and hand sanitizer. Vaccines must maintain a minimum nine-month shelf life from ship date and comply with manufacturer cold chain custody specifications throughout delivery. Offerors must submit a detailed cold chain custody plan, a contingency plan if cold chain requirements are not met, and references from at least two Government points of contact for previous flu vaccine contracts.

NAICS code is 325412, Pharmaceutical Preparation Manufacturing. Offerors must be registered in SAM.gov and provide active points of contact for the Dormant Account Review, Quarterly process. Invoices must be submitted via the Invoice Processing Platform (IPP) at www.ipp.gov. Contracting Officer is Kathleen A. Dee (636-321-6116; kathleen.a.dee@coe.ic.gov).